Further complicating the interpretation of the results, a recent study indicates that BRCA1-mutated tumors (n = 17) have a more immunosuppressed tumor microenvironment as compared to BRCA1 wild-type tumors, as evidenced by higher expression of immunoregulatory and suppressive genes [54]. The gene discussed is BRCA1; the disease is neoplasm.